Background and Purpose: This study was conducted to evaluate the role of high serum lipoprotein(a) levels in a group of patients with a relatively early onset of cerebral infarction as a whole and in a subgroup with the perforating artery occlusion subtype of cerebral infarction.
L ipoprotein(a) [Lp(a)] was initially detected by
Berg1 in 1963. Lp(a) has a low-density lipoprotein (LDL)-like structure, in which apolipoprotein(a) [apo(a)] is covalently linked to apolipoprotein B. In addition, the structural similarity between apo(a) and human plasminogen has been revealed.2 It has also been reported that apo(a) inhibits plasminogen from binding to receptors in endothelial cells and facilitates thrombogenesis. [3] [4] [5] [6] [7] [8] It is rational to regard high Lp(a) levels as a potential risk factor for both atherogenesis and thrombogenesis.3-7 Indeed, in cardiology it is established that high Lp(a) levels are an independent risk factor for the development of ischemic heart disease. [8] [9] [10] Serum Lp(a) levels have been reported to be under considerable genetic control.11' 2 Serum Lp(a) levels are not significantly correlated with age, sex, blood pressure, smoking habits, total cholesterol, or triglycerides,13 and they are relatively resistant to pharmacological and dietary restrictions. '4-16 In general, environments such as food, drugs, and habits do not seem to change the value of Lp(a).17 It is suggested, however, that serum Lp(a) levels have a tendency to increase in subjects with diabetes mellitus (DM).18 The Lp(a) distribution in the normal population is highly skewed, and a clinically important Lp(a) threshold level is now being discussed. 14"19 In neurology, the role of Lp(a) in the development of cerebral infarction, including the cortical artery occlusion (CAO) type, has also been suggested.20-22 It is not clear, however, whether high serum Lp(a) levels are an independent risk factor for cerebral infarction. In previously reported studies, atrial fibrillation (AF) was not referred to20'2' and subjects with AF were not excluded in the statistical analysis.22 When subjects with AF are not excluded, there is a great possibility that the data include subjects with cardiac embolic strokes. In addi-tion, two of these three reports described a negative association of a high Lp(a) level with the perforating artery occlusion (PAO) type of cerebral infarction. 20, 22 The aim of the present study is to elucidate the positive or negative association of a high Lp(a) level with cerebral infarction as a whole and with the PAO subtype when excluding subjects with AF.
In this study we used magnetic resonance imaging (MRI) to separate the patients into two subgroups, the PAO group and the CAO group. Since MRI can detect smaller and fainter lesions than computed tomography (CT), MRI is superior to CT scanning for detecting PAO Figure. The Lp(a) distribution in the control subjects was highly skewed toward the lower levels. In the cerebral infarction patients, the distribution was slightly skewed and deviated to a higher range compared with the control subjects. The incidence of serum Lp(a) levels .42.6 mg/dL, which is the 95th percentile Lp(a) level of the control subjects, in cerebral infarction patients is summarized in Table 1 . The incidence of high Lp(a) levels was significantly higher in the total cerebral infarction group (P<.01), PAO group (P<.025), and CAO group (P<.05) compared with control subjects when subjects with AF were not excluded. When the nine subjects with AF were excluded, the incidence was still significantly higher in the total cerebral infarction group (P<.025) and the PAO group (P<.025) compared with the control subjects. In the CAO group without AF, the significance was not observed, probably because of the small sample size. Yates' correction.
The serum levels of lipids and fasting blood sugar in patients without AF and control subjects are shown in Table 2 . No statistical differences between the patients and control subjects were observed in the levels of total cholesterol, LDL cholesterol, triglycerides, and fasting blood sugar. The levels of HDL cholesterol were significantly lower in the total cerebral infarction group (P<.01), PAO group (P<.05), and CAO group (P<.05).
The incidence of hypertension, DM, smoking habits, alcohol intake, and positive family history in patients without AF and in control subjects is shown in Table 3 . The incidence of hypertension was significantly higher in the total cerebral infarction group (P<.001) and the PAO group (P<.001) compared with control subjects.
Four biochemical variables (serum levels of Lp(a), LDL cholesterol, HDL cholesterol, and triglycerides) and other potential risk factors listed in Table 3 were analyzed by stepwise logistic regression to determine the independent and significant risk factor for the group with cerebral infarction without AF as a whole and for the PAO subtype group (Table 4) . We identified three significant risk factors in the total and PAO subtype groups of cerebral infarction patients: hypertension, a low HDL cholesterol level, and a high serum Lp(a) level. We did not perform a multivariate analysis of the CAO subtype group because of an insufficient number of subjects.
The history of DM is the only known factor that correlates with serum Lp(a) levels. There was no significant difference in serum Lp(a) levels between patients with DM (n=4) and patients without DM (n=41) (P>.9 by Mann-Whitney U test). In addition, there was no significant correlation between levels of fasting blood sugar and serum Lp(a) levels (r=.03, P>.5 by Spearman's rank correlation coefficient).
Discussion
Murai et a120 first observed a positive association of high Lp(a) levels and the CAO subtype of cerebral infarction in Japanese patients. In their study, however, high Lp(a) levels were not significantly increased in the cerebral infarction group as a whole or in the PAO subtype group. Subsequently, Zenker et a121 reported that the median values of serum Lp(a) levels were significantly higher in white patients with cerebrovascular disease than in control subjects. More recently, Woo et a122 reported that a high Lp(a) level increased the overall risk of stroke, especially cerebral infarction and intracerebral hemorrhage, in Chinese patients. Although we excluded the subjects with AF to omit cardiac embolic strokes from the statistical analysis in the present study, Murai et a120 and Zenker et a121 did not refer to subjects with AF in their studies. On the other hand, Woo et a122 evaluated the risk factors including AF but did not exclude subjects with AF in their multivariate analysis. In addition, in the three studies reported above, brain CT was used for the neuroradiological examinations. In the present study, MRI, which can detect smaller and fainter lesions than CT, was used for the diagnostic examinations. In this 22 Because we selected patients by the onset age of younger than 65 years and the mean age of our patients was younger than in the two aforementioned studies, the discrepancy may be due to the difference in ages. In addition, because MRI can detect smaller and fainter lesions than CT, the difference in methods of examination may also be related to this discrepancy.
Although it has been suggested that serum Lp(a) levels are increased in patients with DM, Lp(a) levels were not related to the history of DM or fasting blood sugar in the present study. The data obtained in this study suggest that high Lp(a) levels are an independent risk factor for cerebral infarction as a whole as well as for the PAO subtype. Since Lp(a) levels are to a great extent controlled by the apo(a) locus,11'2 an association study on cerebral infarction and the apo(a) phenotypes is under way in our laboratories.
